CARL · Carlsmed, Inc. · Executive Compensation
$14.96
-0.81 (-5.14%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$430.56M
Shares
27.30M
Volume · Oct 30
42.1K
Avg daily vol (3M)
111.94K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mike Cordonnier | Chief Executive Officer, President and Co-Founder | $2,789,967 |
| Scott Durall | Chief Commercial Officer | $1,516,272 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mike Cordonnier | Chief Executive Officer, President and Co-Founder | $520,693 |
| Scott Durall | Chief Commercial Officer | $417,087 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard Heppenstall | Chief Financial Officer | Appointed | 2026-09-30 |
| Jeffrey Bertolini | Chief Operating Officer | Appointed | 2026-09-08 |
Leadership
- Mike Cordonnier CEO
- Richard Heppenstall CFO
- Jeffrey Bertolini COO
Key facts
CIK
1794546
CUSIP
14280C105
13F (30d)
13 filings
13 filers
Visit website
Investor relations